Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZS in Hyperkalemia Maintenance
NCT02088073Phase 3Completed
- Sponsor
- ZS Pharma
- Start
- Mar 2014
- Primary completion
- Aug 2014
- Modality
- DNA Intercalators/Alkylators
- Countries
- 3
01
Overview
A Phase 3 trial of sodium zirconium cyclosilicate in hyperkalemia, sponsored by ZS Pharma. Started Mar 2014; status: completed.
02
Drugs
sodium zirconium cyclosilicate
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on NCT02088073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02088073.